Cite
MLA Citation
Inge G.P. Geelen et al.. “Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe.” European journal of haematology, vol. 100, 2018, pp. 367–371. http://access.bl.uk/ark:/81055/vdc_100058125854.0x00003e